Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation
Open Access
- 26 May 2022
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-8
Abstract
The transcriptional machinery is composed of numerous factors that help to regulate gene expression in cells. The function and the fundamental role of transcription factors in different human diseases and cancer have been extensively researched. Activator protein-1 (AP-1) is an inducible transcription factor that consists of a diverse group of members including Jun, Fos, Maf, and ATF. AP-1 involves a number of processes such as proliferation, migration, and survival in cells. Dysfunctional AP-1 activity is seen in several diseases, especially cancer and inflammatory disorders. The AP-1 proteins are controlled by mitogen-activated protein kinases (MAPKs) and the NF-κB pathway. AP-1 inhibitors can be actively pursued as drug discovery targets in cancer therapy when used as a treatment to halt tumor progression. The consumption of phytochemicals in the diet is related to decreasing the incidence of cancer and proves to exhibit anticancer properties. Natural product targets AP-1 are effective cancer prevention and treatment options for various cancer types. Targeting AP-1 with natural products is an effective cancer treatment option for different cancer types. This review summarizes AP-1 subunit proteins, their structures, AP-1-related signaling, and its modulation by natural bioactive compounds.Keywords
Funding Information
- National Research Foundation (2020R1A2B5B01001807)
- Ministry of Science and ICT, South Korea (2020R1A2B5B01001807)
This publication has 72 references indexed in Scilit:
- Inhibition of AP-1 and MAPK signaling and activation of Nrf2/ARE pathway by quercitrinInternational Journal of Oncology, 2009
- Pathogenesis of rheumatoid arthritis and c-Fos/AP-1Cell Cycle, 2009
- AP-1 and colorectal cancerInflammopharmacology, 2005
- Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4Trends in Molecular Medicine, 2003
- Points of control in inflammationNature, 2002
- AP-1 as a regulator of cell life and deathNature Cell Biology, 2002
- Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma CellsJournal of Biological Chemistry, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Fos and jun: The AP-1 connectionCell, 1988